INTRODUCTION
Human papillomaviruses (HPVs) are classified as high-or low-risk according to their oncogenic potential. High-risk HPV types (HR-HPV) are those found in cervical cancer, with HPV types 16 and 18 accounting for almost 70 % of all cervical cancer cases (zur Hausen, 2002) . It is well known that only a small number of cervical lesions infected with HR-HPVs evolve into high-grade lesions or cervical cancer (Bosch et al., 2002) . Many naturally occurring HPV intratype variants have been identified; furthermore, molecular and epidemiological data suggest that variants of the same type are biologically distinct and may confer different pathogenic risks (Berumen et al., 2001; De la CruzHernández et al., 2005; Lizano et al., 1997 Lizano et al., , 2006 . In a previous work examining a Mexican population, three different HPV18 variants were identified, Asian Amerindian (AsAi), European (E) and African (Af), which have been associated with specific histological types of cervical cancer (Lizano et al., 1997) .
HPV replication has two stages in the natural history of infection: a persistent stage, which is characterized by a low copy number of viral episomes, occurring mainly in the basal layer without generating progeny virions (Hubert et al., 1999; Hubert, 2005) ; and a productive stage, where viral genomes are amplified in high copy numbers, later genes are expressed and progeny virions are produced (Hubert, 2005) . E1 and E2 viral proteins are essential for HPV replication. E1 is the most conserved protein among papillomaviruses (Koonin, 1993) , harbouring a C-terminal domain involved in ATP-dependent DNA helicase activity (Abbate et al., 2004; Wilson et al., 2002) . The N-terminal domain is the most variable region of E1 within all papillomaviruses (Abbate et al., 2004) ; nevertheless, it contains two conserved nuclear localization signals (NLS) and a nuclear export signal (NES) (Fradet-Turcotte et al., 2010) . It has been reported that the E1 N-terminal region is essential for viral episome maintenance in undifferentiated primary human keratinocytes due to its interaction with the cellular protein p80, which co-localizes with E1 at the nucleus (Côté-Martin et al., 2008) . The long control region (LCR) contains the origin of replication, ori, harbouring a single E1-and three E2-binding sites (Demeret et al., 1998) . The keratinocyte enhancer (KE) domain contained in the LCR has been described as being directly involved in IP: 54.70.40.11
On: Wed, 24 Apr 2019 19:08:54 modulating ori function (Hubert et al., 1999) . The E2 protein plays an important role in viral replication, forming E1-E2 complexes, which help E1 binding to the ori (Abbate et al., 2004) . The aim of this study was to determine whether nucleotide variations in the LCR and/or E1 or E2 genes of HPV18 intratype variants could affect viral replication. Our results demonstrate that nucleotide variations in these sequences affect replication, with the highest impact for E1-Af.
RESULTS

HPV18 E1 variations reside in the N-terminal region
E1 genes of HPV18 variants (AsAi, E and Af) were sequenced. Nucleotide sequences shared a 99 % of similarity with already reported HPV18 isolates (GenBank accession no. EF202155.1, for the Af variant; GenBank accession no. GQ180786.1, for the E variant). Table 1 lists the nucleotide and predicted amino acid changes found in different regions of the E1 variants. Few changes affecting amino acids were present in the Af or E variants compared to the reference AsAi. Nevertheless, variations were mainly located at the N-terminal region, which is essential for E1 nuclear localization.
Viral ori function is dependent on E1 and E2
Plasmid pORI replication was assessed in the presence and absence of E1 and E2 expressing plasmids, Fig. S1 (available in JGV Online). Semi-quantitative RT-PCR assay showed similar expression levels for E1 and E2 in each transfection, Fig. S2 . No replication was found with pORI alone or pORI/E2 and minimal replication occurred with pORI/E1, compared when both E1 and E2 were present, where there was an approximately 24-fold amplification. The results confirm that pORI replication is dependent on the E1 and E2 genes. In these experiments it was ensured that the amount of input plasmid was uniform. It was demonstrated that input dam-methylated DNA was comparable in all experiments, after digesting unmethylated DNA with MboI enzyme, Fig. S3 . Therefore, differences observed in replication should be due to the biological effect of variations in the tested genes.
Variations in the LCR affect ori function
The E1 and E2 DNA-binding domains (DBDs) are conserved within papillomaviruses, as well as the respective LCRbinding consensus sequences (Auster & Joshua-Tor, 2004; Hegde & Androphy, 1998; Titolo et al., 2003; ) . Moreover, it has been previously suggested that viral proteins E1 and E2 may support the replication of homologous and heterologous papillomaviruses (Chiang et al., 1992) . In a previous study, variations in the LCR of HPV18 E and Af sequences were reported (Ló pez-Saavedra et al., 2009), particularly in the KE region, known to be involved in viral ori replication (Hubert, 2005) . Hence, it was of our interest to analyse whether LCR variations could impact ori replication.
Plasmids expressing E1 and E2 (p40-E1AsAi and pCGE2AsAi) were co-transfected with each of the LCR variants (pORI-AsAi, -E or -Af) as the only variable. Fig. 1(a) shows that pORI-AsAi had the highest ori function since pORI-Af and pORI-Eu were amplified to almost half of the number of copies of pORI-AsAi (P,0.05). A similar trend was observed for transfected C33 and HaCaT cell lines, where pORI-AsAi had the highest ori function, although some variations in pORI-Eu and pORI-Af replication occurred within cell lines, Fig. 1(b) and (c).
Variations in the E1 gene affect ori function Next, we sought to determine whether the changes in E2 variant genes could modify ori function. Co-transfections of p40-E1AsAi and pORI-AsAi plasmids with those expressing E2 variants (AsAi, E or Af) as the only variable were performed. As shown in Fig. 2(a) , no significant changes in pORI-AsAi amplification were found, related to the tested E2 variants in HEK-293. The same effect was observed for transfected C33 and HaCaT cells lines, Fig. 2(b) and (c). Therefore, the analysed E2 variations do not affect ori function.
To evaluate the effect of variations in E1, pCG-E2AsAi and pORI-AsAi were co-transfected in HEK-293 cell line, with plasmids expressing the different E1 variant genes (AsAi, E or Af) as the only variable. As observed in Fig. 3(a) , the presence of E1-Af caused a significantly higher pORI-AsAi amplification than that observed with E1-AsAi or E1-E (P,0.05). This result shows that E1-Af, is able to augment the previously demonstrated strong ori function of pORIAsAi, in comparison to E1-AsAi, Fig. 1 . This trend was reproduced in other cell lines, as demonstrated when HaCat keratinocytes and cervical cancer-derived C33, were tested. As shown in Fig. 3(b) and (c), E1-Af promotes the highest replication level of pORI-AsAi in those cellular contexts.
We next tested the effect of variant homologous elements by the analysis of the ori function of each variant in the presence of the corresponding E2 and E1 variant genes in HEK-293. In this context, the highest effect was observed for pORI-Af-related amplification as shown in Fig. 4(a) , even it previously appeared weaker than pORI-AsAi in the presence of E1-and E2-AsAi, The observed effect on ori function was not due to slight differences in E1 concentration, as observed through transfections of HEK-293, C33 and HaCaT cell lines with p40-E1-Af in concentration gradient. Fig. S4(a) , (b) and (c) show that E1-Af affect ori replication in a dose-dependent manner, where .0.8 mg p40-E1-Af plasmid overload E1 enzymic function in all cell lines. In the present study an amount of 1.75 mg p40-E1 was used for all transfections.
Nuclear localization of E1 variants
Nuclear localization of E1 is essential for its helicase function. Therefore, it is possible that E1 variations in the N-terminal domain, Table 1 , could impact on protein localization explaining the observed differences related to ori replication.
To compare E1 nuclear localization among variants, immunofluorescence analysis was performed on C33 cells transfected with plasmids containing E1 variants tagged with HA. As shown in Fig. 5 (a), a stronger HA signal was observed in the nucleus of cells transfected with E1-Af, compared to those with E1-AsAi, with only a subtle difference for E1-Eu. E1 real-time PCR assays were performed, confirming that there were no significant differences in RNA expression and neither in DNA-copy number of the introduced pE1-HA. This trend was reproducible when E1, E2 and LCR of each variant were transfected altogether, Fig. 5 
(b).
Three of the E1-Af nucleotide variations result in amino acid substitutions, related to the reference E1-AsAi. The participation of these variations in the observed nuclear accumulation was evaluated. Through direct mutagenesis the respective changes at positions 1256, 1378 and 1470 from the Af variant were introduced one by one into the E1-AsAi variant. With single mutations, nuclear signal intensity slightly increased in relation to that previously observed for E1-AsAi, Fig. 5(c) . Double mutations were also tested and surprisingly, the changes at positions 1256 and 1470 resulted in greater E1 nuclear accumulation, similar to that obtained for E1-Af, Fig. 5 (c). , 1997, 2006) .
In the present study, it was examined whether intratype variations of E1, E2 or the LCR may affect viral ori function. We found that E1 intratype variations significantly impact ori function; the highest ori activity was found in the context of E1 Af variant.
Variations in the HPV18 LCR also affect ori function since a significant higher pORI amplification was obtained with LCR-AsAi compared with the other LCR variants tested. This effect may be related to the changes found in the KE region as it has been reported that mutations in this domain affect HPV replication (Hubert et al., 1999 Interesting results were obtained with regard to E1 variants. The presence of Af and E E1 variants increased replication compared with E1-AsAi. Variations reside in the Nterminal region of the E1 predicted proteins, where nuclear localization (NLS) and export (NES) signals are located.
On the other hand, it has been shown that changes in Nterminal, particularly in the amphipathic helix may alter replication (Morin et al., 2011) .
After examining the importance of variations in each of the elements responsible for HPV replication, we then analysed the effect within a unique variant context, namely attesting the E1, E2 and LCRs of the same variants. It was demonstrated that replication variability was mainly due to changes in E1, even in the presence of homologous elements. This finding could be reproduced in distinct cellular contexts, since E1-Af also had the highest impact in ori function in C33 and HaCaT cell lines as in HEK-293.
We then analysed whether differences in replication level could be due to a disparity in variant E1 nuclear levels.
Immunofluorescence results showed that E1-AsAi protein was moderately detected in the nucleus, while E1-Af had the strongest nuclear signal, correlating with the enhanced ori function. This trend was similar when immnunofluorescence was performed in cells transfected with E1, E2 and the LCR of each variant. When Af nucleotide changes at positions 1256, 1378 and 1470 were introduced in the AsAi E1 gene, E1 nuclear intensity augmented, particularly with the double mutant 1256-1470. The respective predicted amino acids (positions 115, 157 and 186) could be part of a domain that impact E1 nuclear stability. Nevertheless, even that mRNA E1 levels were similar; it is possible that the increased levels of Af E1 in the nucleus is due to higher steady-state levels of the protein.
On the other hand, even replication differences are clear, E E1 showed only a subtle difference in nuclear signal related to the Af E1. Therefore, even nuclear accumulation may have a main role in ori replication, other unknown mechanisms could also be participating. E1 was not detected in any case at the cytoplasm, probably evidencing that this protein is mainly stable in the nucleus.
The present data demonstrate that changes in the E1 gene affect ori function, and differences in replication among variants could be explained partially by its nuclear accumulation, but mechanisms such as post-translational modifications, enzymic cleavage, as other unknown mechanism could play an important role in this biological effect. However, our results suggest that E1 variations could impact the natural history of HPV infection, mainly affecting viral episome copy number.
In previous reports, we proposed that the HPV18 Af variant could exhibit a less aggressive behaviour (Ló pez-Saavedra et al., 2009; De la Cruz-Hernández, et al., 2005) based on data obtained through the analysis of the LCR activity and E6 oncogene function. The results obtained in this work show that the Af E1 has the highest impact on replication. Other authors proposed that a high viral load is a potential risk factor for the development of high-grade cervical lesions (Broccolo et al., 2009; Flores et al., 2006; Xu et al., 2009; Wanram et al., 2009; ) , someway contrasting with our data. The HPV18 Af variant has a lower oncogenicity for certain so it could not be discarded that a high number of HPV copies at initial infection, due to an overregulation of E1 function, could consequently be linked to a high expression of the E1 and E2 proteins. Moreover, it has been demonstrated that the E2 protein controls viral early gene expression and induces apoptosis (Demeret et al., 2003) . Therefore, an HPV variant promoting an increase in viral replication could have a diminished transforming potential. Furthermore, Fradet-Turcotte et al. (2011) demonstrated that the nuclear export of E1 is required for the maintenance of the viral genome in undifferentiated keratinocytes but not for its amplification in differentiated cells, suggesting that the increased levels of E1 in the nucleus could create a favourable environment for viral DNA amplification by blocking cells in the S-phase. This blockage would induce DNA damage response by ATM-dependent pathway, promoting DNA repair or leading to apoptosis.
To closer define the impact of HPV intratype variations on the oncogenic potential, it would be necessary to explore the biological implication of other viral interactions with cellular targets.
METHODS
Plasmid construction. The pCG-E2 plasmids contain versions of the HPV18 E2 variant genes (E, AsAi and Af) cloned into pCG vector. Plasmids were named pCG-E2AsAi, pCG-E2E and pCG-E2Af according to each HPV18 variant type. Variants of the HPV18 LCRs (E, AsAi and Af) were cloned into the pGL2-basic reporter vector (Promega), resulting in the pORI-AsAi, pORI-E and pORI-Af plasmids. The nucleotide sequences of the E2 genes and LCRs have been previously reported (Ló pez-Saavedra et al., 2009). The E1 AsAi gene was PCR amplified from pBR322-HPV18 (a kind gift from Professor H. zur Hausen, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany), which contains the entire genome of the HPV18 AsAi variant, using the following primers: forward: 59-GGGGGATCCATGGCTGATCCAG-39 (nt 914-926) and reverse: 59-GGGAAGCTTCTAATCTGGACCA-39 (nt 2783-2795). The resulting PCR product was cloned into the pXJ40 FT vector (p40), described by Xiao et al. (1991) , to obtain p40-E1AsAi.
Recombinant pE1-HA plasmids containing E1-AsAi, -E or -Af variants were constructed from pcDNA 3.3 TOPO vector. E1 variant genes were PCR-amplified from the p-40-E1 vectors using the following primers: forward, 59-GCCATGGGCTACCCATACGATGT-TCCAGATTACGCTGACGATGACGATAAGATGGCTGATCCAGAA-GGTACA-39; reverse, 59-CTATCTGGACCATGTCCTTTCAAA-39.
The obtained product contained a haemagglutinin domain at the E1 N terminus. The plasmids were constructed with the pcDNA Single and double mutations at positions 1256, 1370 and 1470 were introduced in the plasmid pE1-HA AsAi, to obtain three AsAi mutants with an Af site (1256, 1378 or 1470) and three AsAi mutants with two Af sites (1256-1378, 1256-1470 and 1378-1470) . The primers used were the same as those shown in Tables S1 and S2 . Mutants were confirmed by direct sequencing (see Figs S7 and S8).
E1 gene sequences. E1 nt sequences were obtained from overlapping PCR products from pre-malignant lesions of the cervix containing HPV18 E or Af variants (Lizano et al., 2006) . Three samples for each variant were sequenced. The obtained sequence of the E1-AsAi gene from plasmid pBR322-HPV18 was confirmed using the published HPV18 AsAi sequence (HPV Sequence Database, http://www.stdgen.lanl.gov). Direct sequencing was performed from PCR products using the Big Dye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems). Primers used to amplify the E1 genes are showing in Table S3 . RNA extraction and expression analysis. To determine E1 and E2 expression, total RNA was extracted from transfected cells with TRIzol (Invitrogen Life Technologies) according to the manufacturer's instructions. Samples were treated with 1 U DNase I (Gibco-BRL). The amount of RNA was determined by UV spectrophotometry, and the RNA quality was confirmed using 2 % agarose gels. For cDNA preparation, 2 mg total RNA was reverse-transcribed with random hexamers using the SuperScript first-strand synthesis system for RT-PCR (Invitrogen Life Technologies). cDNA was PCR-amplified for E1 and E2-expression analysis.
Immunofluorescence. Duplicate assays were performed in C33 cells transfected with 800 ng of pE1-HA plasmids. At 24 h post-transfection one sample was fixed for 20 min at room temperature in 4 % paraformaldehyde. Then, cells were rinsed with PBS, and permeabilized for 5 min at room temperature with 0.2 % Triton X-100. Then, cells were incubated with 0.1 M glycine in PBS to quench free aldehyde groups. Primary antibody anti-HA [HA-probe (Y-11): sc-805, Santa Cruz Biotechnology] was incubated in PBS for 1 h at room temperature. After washing with PBS (36, 10 min each), cells were incubated for 30 min at room temperature with anti-goat Alexa-488 secondary antibody diluted in PBS. Finally, cells were washed with PBS (36, 10 min each), counterstained and mounted with Prolong Gold Antifade Reagent (Invitrogen). The second sample was used for realtime RT-PCR and real-time PCR E1 assays.
Confocal microscopy. Images were collected with an LSM710-DUO confocal laser system couple to an AxioObserver inverted scanning microscope (Zeiss) and were analysed using LSM Image Browser version 3.2.0.70 (Zeiss). Images were acquired with a 640 objective (E1-AsAi, E and Af) and 660 for the empty vector control.
E1 quantitative real-time PCR (qRT-PCR). E1 copy number (from DNA) and transcript levels (from cDNA) were measured in cells tested for E1 confocal microscopy. The quantity of E1 transcript was calculated by DDC t . The primers used to amplified E1 and GAPDH genes were: E1-914-F: 59-ATGGCTGATCCAGAAGGTACA-39, E1-1125-R: 59-TGGAACAATGCCTGTCGTGTC-39 and GAPDH-F: 59-TGCACCACCAACTGCTTAGC-39, GAPDH-R: 59-GGGATGGACT-GTGGTCATGAG-39. E1 quantification was performed using a standard curve from pE1-HA with dilution series from 1610 3 to 1610 9 copy number.
cDNA was obtained by GeneAmp (RNA PCR kit; Applied Biosystems). E1 qRT-PCR was performed with SBYR Green (Applied Biosystems). PCR was optimized for 300 nM of reverse and forward E1 and GAPDH primers, on a StepOnePlus real-time PCR system (Applied Biosystems) with the following PCR conditions: 95 uC for 30 s and 60 uC for 1 min for 40 cycles.
DNA harvest. Low molecular mass DNA was extracted 72 h after transfection by using the Hirt method (Morgan & Taylor, 2005; Taylor & Morgan, 2003) . Briefly, cells were lysed in 400 ml Hirt solution (0.6 % SDS, 10 mM EDTA) and scraped into a 1.5 ml microcentrifuge tube; 100 ml 5 M NaCl was added, and the samples were stored at 4 uC overnight. After centrifugation for 30 min at 4 uC, DNA was extracted once with phenol/chloroform-isoamyl-alcohol and precipitated with 100 % ethanol and ammonium acetate (pH 5.2, 3 M). Following centrifugation, the DNA pellet was washed with 70 % ethanol, dried and then suspended in 50 ml dH 2 O. Plasmid replication was analysed using real-time PCR.
Plasmid replication assay. To test pORI plasmid replication, a 130 bp fragment of the luciferase gene contained in the pGL2-basic plasmid was amplified. This fragment contains two DpnI sites, which are necessary to evaluate de novo replication in HEK-293 cells. The primers used to amplify the luc fragment were: Luc-Sense-59-TCGTCACATCTCATCTACCTCC-39 and Luc-Antisense-59-CGAG-AATCTGACGCAGGCAGT-39.
Real-time PCR assays were performed using SBYR Green (Applied Biosystems). PCR conditions were optimized to 50 nM Luc-Sense primer and 300 nM Luc-antisense primer. PCRs were performed on an ABI Prism 7700 detection system (Applied Biosystems) with the following PCR conditions: 95 uC for 30 s and 60 uC for 1 min for 40 cycles.
Harvested DNA was digested with either DpnI or MboI. DpnI can only digest GATC sites when both DNA strands are dam-methylated (dam positive, a bacterial-specific methylation at adenines), whereas MboI digestions are only possible when both strands are unmethylated at the adenines. Therefore, DpnI will not digest DNA replicated in eukaryotic cells, and MboI will not digest input DNA (methylated in bacteria). The digestion conditions were previously described (Morgan & Taylor, 2005; Taylor & Morgan, 2003) . To detect replicated pORI-(AsAi, E or AF), 25 ml sample were digested with DpnI; to detect input plasmid, 25 ml of sample were digested with MboI. Exonuclease III digestion was performed for 30 min to reduce the amount of incompletely digested DNA (Taylor & Morgan, 2003) . Two microlitres of each treated sample was analysed in triplicate using real-time PCR. Quantification was performed using a standard curve from pORI-AsAi (which contains the luciferase fragment to be amplified) with dilution series from 1610 3 to 1610 9 copy numbers.
Statistical analysis. Differences in plasmid replication levels were analysed with Student's t-test, expressing replication levels as copy number±1 SD.
